Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
6.48
-0.12 (-1.82%)
Mar 31, 2025, 10:47 AM EDT - Market open
Phathom Pharmaceuticals Revenue
In the year 2024, Phathom Pharmaceuticals had annual revenue of $55.25M with 8,001.47% growth. Phathom Pharmaceuticals had revenue of $29.66M in the quarter ending December 31, 2024, with 4,249.56% growth.
Revenue (ttm)
$55.25M
Revenue Growth
+8,001.47%
P/S Ratio
7.55
Revenue / Employee
$129,396
Employees
427
Market Cap
443.09M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
PHAT News
- 2 hours ago - Actor and Comedian Kenan Thompson Teams Up with Phathom Pharmaceuticals to Raise Awareness About GERD and VOQUEZNA® (vonoprazan) - GlobeNewsWire
- 24 days ago - Phathom Pharmaceuticals, Inc. (PHAT) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 25 days ago - Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 6, 2025 - GlobeNewsWire
- 2 months ago - Phathom Pharmaceuticals to Present at the Guggenheim Securities SMID Cap Biotech Conference - GlobeNewsWire
- 3 months ago - Phathom Pharmaceuticals Submits Citizen Petition to FDA Seeking Correction of Orange Book Listings for VOQUEZNA® (vonoprazan) Tablets - GlobeNewsWire
- 5 months ago - Phathom Pharmaceuticals, Inc. (PHAT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire